Company develops endoscopically implantable devices to control appetite and regulate glucose production in patients with metabolic disorders. Develops bionic and implantable neurostimulation devices involved in the treatment of a variety of physical and physiological dysfunctions. Offers portfolio of cancer therapeutic drugs based on its proprietary tumor-targeting platform and drug delivery system.
Company develops endoscopically implantable devices to control appetite and regulate glucose production in patients with metabolic disorders. Develops bionic and implantable neurostimulation devices involved in the treatment of a variety of physical and physiological dysfunctions. Offers portfolio of cancer therapeutic drugs based on its proprietary tumor-targeting platform and drug delivery system.
Company develops endoscopically implantable devices to control appetite and regulate glucose production in patients with metabolic disorders. Develops bionic and implantable neurostimulation devices involved in the treatment of a variety of physical and physiological dysfunctions. Offers portfolio of cancer therapeutic drugs based on its proprietary tumor-targeting platform and drug delivery system.
Produces endoscopically implantable devices to control appetite and
Endosphere Tuesday 8:30 AM regulate glucose production in patients with metabolic disorders
Is developing an early-stage human health vaccine pipeline
ImmunoVaccine Tech Tuesday 8:45 AM consisting of infectious disease and therapeutic cancer products Manufactures bionic and implantable neurostimulation devices Victhom Human Bionics involved in the treatment of a variety of physical and physiological Tuesday 9:00 AM dysfunctions, including gait disorders Is developing catheter-based products to improve outcomes for Genesis Medical Tuesday 9:15 AM patients suffering from occlusive vascular diseases
Offers a portfolio of cancer therapeutic drugs based on its
NeoPharm Tuesday 9:30 AM proprietary tumor-targeting platform and drug delivery system Is developing and commercializing a three-dimensional approach to NewCardio Tuesday 9:45 AM electrocardiography Provides implantable mechanical heart assist devices for patients Sunshine Heart Tuesday 10:00 AM with moderate to severe chronic heart failure
Develops and commercializes proprietary cell-based technologies
ISTO Tuesday 10:15 AM designed to regenerate and restore damaged cartilage and bone
Operates a full service technology licensing and incubator program
UAMS BioVentures Tuesday 10:30 AM for medical device and pharmaceutical start-up companies
Utilizes a patent-pending technology that powers implantable
Endurance Rhythm Tuesday 10:45 AM cardiac devices using energy from the beating heart Specializes in cryoablation technologies for the treatment of Endocare Tuesday 11:00 AM prostate cancer Offers catheter products that facilitate the local delivery of cells, BioCardia gene, and protein therapeutics to the heart, along with cardiac Tuesday 11:15 AM regenerative medicine systems involving autologous stem cells Incorporates proprietary 'Occlusion Spectroscopy' technology for Orsense Tuesday 11:30 AM non-invasive glucose monitoring
Developing the only patented micro-current stimulation device for
ScyFix Tuesday 11:45 AM the treatment of macular degeneration, Stargardt's disease, retinitis pigmentosa and other degenerative eye diseases Specializes in the novel unit dose packaging of drugs and develops Mystic Pharmaceuticals Tuesday 1:30 PM precision delivery systems for various applications
Has developed referenced EEG (rEEG) technology to assess the
CNS Response presence of individual neurophysiologic abnormalities and to guide Tuesday 1:45 PM subsequent psychiatric treatment Seeks to pioneer and commercialize therapeutic applications of Silere Medical electronic neurostimulation technology targeting tinnitus and other Tuesday 2:00 PM auditory conditions Has developed a patented pathogen inactivation technology for Clearant biological products, including soft tissue allograft implants and bone Tuesday 2:15 PM allografts. Designed and patented a Fully Implantable Hearing System that Crescendo Biotech directly stimulates the cochlear fluid, provides improved speech Tuesday 2:30 PM recognition in noisy environments, and is completely invisible Is developing disposable catheter-based technology to detect and Minnow Medical shrink atherosclerotic plaques implicated in the progression of Tuesday 2:45 PM peripheral artery disease (PAD) Facilitates minimally-invasive implantation of artificial chordae NeoChord Tuesday 3:00 PM tendineae to improve outcomes of mitral valve regurgitation Offers proprietary biopolymer and biotherapeutic devices for the Symphony Medical treatment of Congestive Heart Failure (CHF) and post-operative Tuesday 3:15 PM atrial fibrillation (POAF) Creates novel technology to enable the diagnosis of lipid-core InfraReDx Tuesday 3:30 PM containing plaques in the coronary arteries Developing innovative, implantable devices that repair heart valve MitralSolutions, Inc. Tuesday 3:45 PM abnormalities Develops next-generation drug-delivery approaches to treating Medlogics coronary artery disease, as well as creating drug-eluting stent Tuesday 4:00 PM technology Developed fully-integrated pattern scan laser system to treat retinal Optimedica Tuesday 4:15 PM diseases Markets pain management solutions, such as disposable pain pumps, Symbios Tuesday 4:30 PM for use in post-surgical patients Provides device that entraps and removes potentially obstructive PercSys Tuesday 4:45 PM materials from the ureter during urological and endoscopic surgeries Develops innovative devices that allow women and their doctors to NeoMatrix Wednesday 8:30 AM promote optimal breast health
Develops containers used to transport food, water, and medical
Carego Intl. Wednesday 8:45 AM supplies to disaster areas, which then transform into fully efficient, self contained medical facilities. Created a three-dimensional and web-based biomechanical Sherlock-NMD diagnostic system measuring motion in patients with Wednesday 9:00 AM musculoskeletal dysfunction Provides advanced revenue cycle management technology and MedSynergies transactional support to help healthcare management organizations Wednesday 9:15 AM improve operating processes, medical billing and cash flow Introduced innovations in signal processing for the noise and Data-Physics vibration community, including dynamic signal analyzers, vibration Wednesday 9:30 AM controllers and shakers
Offers a proprietary portfolio of high-margin cardiovascular and
PrognostiX Wednesday 9:45 AM inflammatory biomarkers for cardiovascular diagnostic testing
Developing collagen-based bioimplants to reinforce the repair or
Pegasus Biologics Wednesday 10:00 AM reconstruction of soft tissues Developed, and currently markets, minimally invasive three- SuperDimension dimensional imaging for the diagnosis and treatment of distal lung Wednesday 10:15 AM disease Offers health connectivity software suites that streamline Kryptiq Corporation information sharing among healthcare professionals, health Wednesday 10:30 AM insurance plans, patients and other colleagues
Provides minimally invasive, site-specific and image-guided cancer
Nu Vue management systems based on proprietary guided ultrasound and Wednesday 10:45 AM chemotherapeutic encapsulation technologies Provides an interactive social network offering resources and services to support the adoption of healthy gaming as a means to Gaming For Health Wednesday 11:00 AM improve health education, condition management, fitness and quality of life Developed a high-field dedicated purpose MRI system specifically for ONI Wednesday 11:15 AM orthopedic extremity imaging
Applies its patented 'systems pathology' platform-a combination of
Aureon Laboratories, Inc. imaging technology, clinical data, and advanced mathematics-to Wednesday 11:30 AM assess the likelihood of disease progression for various conditions, including prostate cancer Develops ophthalmic devices for the diagnosis and treatment of age- Occulogix Wednesday 11:45 PM related eye diseases Develops and commercializes anti-adhesion and drug delivery SyntheMed products incorporating its proprietary bioresorbable polymer Wednesday 1:30 PM technology Provides integrated drug dispensing devices and usage tracking MedicaSafe systems to improve medication adherence and compliance among Wednesday 1:45 PM patients Designs, develops, manufactures and markets bioabsorbable Coapt Wednesday 2:00 PM products for use in facial aesthetic and rejuvenation procedures Introduced a miniaturized and compact heart-lung machine for LifeBridge Medical Wednesday 2:15 PM Emergency Cardiopulmonary Support (ECPS) Developing producing and distributing innovative and anatomically OrthoPediatrics appropriate orthopedic devices for children and patients of small Wednesday 2:30 PM stature Provides comprehensive and advanced cancer diagnosing services, Clarient identifies optimal drug and therapy strategies for individual patients, Wednesday 2:45 PM and monitors patients undergoing therapy
Provides healthcare with real-time location applications for safe,
Radianse Wednesday 3:00 PM effective and room-level patient tracking and asset tracking Manufactures a 3D oriented matrix which mimics the matrices found CollEngin Wednesday 3:15 PM in human skin and tendons Specializes in molecular tests that detect the irregular gene or Diagnocure Wednesday 3:30 PM protein activity patterns associated with cancer Is developing real-time PCR based diagnostic devices for the Enigma Diagnostics Limited detection and identification of infectious organisms in Wednesday 3:45 PM environmental, clinical and biological samples Produces disposable sensors and electrodes for the diagnostic Dymedix Corporation Wednesday 4:00 PM testing and treatment of sleep disorders Provides tools to track health statistics in a calendar format and Health Analytic Services instantly integrates your data into a complete and clear report that Wednesday 4:15 PM (TheCarrot.com) you can share with whomever you like Offers a diagnostic solution using Holographic Ultrasound to detect Advanced Imaging Tech and characterize breast lesions, particularly in women with dense Wednesday 4:30 PM breast tissue Provides non-invasive 'Dynamic Motion Therapy' for various applications, including the prevention and treatment of bone loss Coaxia Wednesday 4:45 PM associated with osteoporosis, maintenance of musculoskeletal stability and enhancement of the circulatory system
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies With Potent and Broad Neutralizing Activity